[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336773-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336773-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-ctdna-and-liquid-biopsy-in-the-diagnosis-and-monitoring-of-head-and-neck-cancer-towards-precision-medicine","The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine","","Head and neck cancers show rising worldwide incidence and mortality, and current diagnosis and monitoring rely on clinical examination, imaging, and invasive biopsies. These approaches can be costly and time-consuming and may miss recurrence due to inherent inaccuracies. Liquid biopsy analyzes patient bodily fluid biomarkers in a cost-effective and convenient manner, offering insight into biogenetic and biomolecular processes. Monitoring biomarkers such as circulating tumor DNA, circulating tumor cells, and circulating cell-free RNA supports screening, diagnosis, prognostication, and follow-up, including viral and non-viral ctDNA, and highlights future research directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-ctdna-and-liquid-biopsy-in-the-diagnosis-and-monitoring-of-head-and-neck-cancer-towards-precision-medicine/336773/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-ctdna-and-liquid-biopsy-in-the-diagnosis-and-monitoring-of-head-and-neck-cancer-towards-precision-medicine/336773.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are current diagnostic and monitoring methods for head and neck cancer limited?","Question",{"text":63,"@type":64},"Standard approaches include clinical examination, imaging, and invasive biopsy. They can be expensive, slow, uncomfortable for patients, and may have inaccuracies in detecting recurrence.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is liquid biopsy and what biomarkers does it measure in head and neck cancer?",{"text":68,"@type":64},"Liquid biopsy analyzes biomarkers from patient bodily fluids, including circulating tumor DNA (ctDNA), circulating tumor cells, and circulating cell-free RNA, as well as viral and non-viral ctDNA signals.",{"name":70,"@type":61,"acceptedAnswer":71},"How does ctDNA analysis support clinical decision-making?",{"text":72,"@type":64},"Biomarker monitoring via liquid biopsy supports screening, diagnosis, prognostication, and monitoring of patients across different head and neck cancer forms, including linking mutations and methylation patterns to outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336773,1790557964,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","cancers   \nReview  \nThe Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards  \nPrecision Medicine  \nSami I. Nassar 1, Amber Suk 2, Shaun A. Nguyen 1, Dauren Adilbay 1, John Pang 2 and Cherie-Ann O. Nathan 2, *  \nCitation: Nassar, S.I.; Suk, A.; Nguyen, S.A.; Adilbay, D.; Pang, J.;  \nNathan, C.-A.O. The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine.  \nCancers 2024, 16, 3129. [https://](https://)[ ](https://)[doi.org/10.3390/cancers16183129](doi.org/10.3390/cancers16183129)  \nAcademic Editor: Hideya Yamazaki  \nReceived: 20 August 2024  \nRevised: 8 September 2024  \nAccepted: 10 September 2024  \nPublished: 11 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Otolaryngology—Head and Neck Surgery, Medical University of South Carolina, Charleston, SC 29425, USA; [nassar@musc.edu](nassar@musc.edu) (S.I.N.); [nguyensh@musc.edu](nguyensh@musc.edu) (S.A.N.); [adilbay@musc.edu](adilbay@musc.edu) (D.A.)  \n2 Department of Otolaryngology—Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA; [amber.suk@lsuhs.edu](amber.suk@lsuhs.edu) (A.S.); [john.pang@lsuhs.edu](john.pang@lsuhs.edu) (J.P.)  \n* Correspondence: [cherieann.nathan@lsuhs.edu](cherieann.nathan@lsuhs.edu); Tel.: +1-(318)-675-6262  \nSimple Summary: Liquid biopsy’s use in the field of head and neck cancer has garnered interest due to providing an efficient and insightful alternative or complement to the present standards for the diagnosis and monitoring of patients. Certain biomarkers have been associated with specific cancer diagnoses, responses to treatment, and risk of recurrence, including circulating tumor DNA. Analysis of circulating tumor DNA and viral DNA via liquid biopsy has linked certain mutations and methylation patterns to various patient outcomes across several types of head and neck cancer. The present paper has reviewed the recent literature examining liquid biopsy’s clinical utility in head and neck oncology and has discussed the clinical implications of aspects of circulating tumor DNA, among other biomarkers.  \nAbstract: Recent data have shown a continued rise in the worldwide annual incidence and mortality rates of head and neck cancers. The present standard for diagnosis and monitoring for disease recurrence or progression involves clinical examination, imaging, and invasive biopsy techniques of lesions suspected of being malignant. In addition to limitations relating to cost, time, and patient discomfort, these methodologies have inherent inaccuracies for detecting recurrence. In view of these limitations, the analysis of patient bodily fluid samples via liquid biopsy proposes a cost-effective and convenient alternative, which provides insight on the biogenetic and biomolecular underpinnings of oncologic disease processes. The monitoring of biomarkers for head and neck cancer via liquid biopsy, including circulating tumor DNA, circulating tumor cells, and circulating cell-free RNA, has shown clinical utility in the screening, diagnosis, prognostication, and monitoring of patients with various forms of head and neck cancer. The present review will provide an update on the current literature examining the use of liquid biopsy in head and neck cancer care and the clinical applicability of potential biomarkers, with a focus on viral and non-viral circulating tumor DNA. Possible future avenues for research to address specific shortcomings of liquid biopsy will be discussed.  \nKeywords: head and neck cancer; liquid biopsy; ctDNA; squamous cell carcinoma; oropharyngeal carc","cbCaikTpcJHYBmrT","https://ap.wps.com/l/cbCaikTpcJHYBmrT","pdf",1171710,28,"English","# Introduction\n## Background on head and neck cancer and current diagnostic approaches\n## Liquid biopsy and circulating nucleic acids (cfDNA)\n## Mechanisms of DNA release and relevance to ctDNA","[{\"question\":\"Why are current diagnostic and monitoring methods for head and neck cancer limited?\",\"answer\":\"Standard approaches include clinical examination, imaging, and invasive biopsy. They can be expensive, slow, uncomfortable for patients, and may have inaccuracies in detecting recurrence.\"},{\"question\":\"What is liquid biopsy and what biomarkers does it measure in head and neck cancer?\",\"answer\":\"Liquid biopsy analyzes biomarkers from patient bodily fluids, including circulating tumor DNA (ctDNA), circulating tumor cells, and circulating cell-free RNA, as well as viral and non-viral ctDNA signals.\"},{\"question\":\"How does ctDNA analysis support clinical decision-making?\",\"answer\":\"Biomarker monitoring via liquid biopsy supports screening, diagnosis, prognostication, and monitoring of patients across different head and neck cancer forms, including linking mutations and methylation patterns to outcomes.\"}]","The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine | PDF",1790016564,71,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6080359b7ee36de22a7d4221cfd0d12.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/534f7b6110c58e84a0e29b07458e3042.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e83acac3d9b28ac27eaba0f4df1c75ed.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c9eee2e622d626fe3d61fc8185714a0.webp",980,1385]